The DEK Oncogene Is a Target of Steroid Hormone Receptor Signaling in Breast Cancer

Overview of attention for article published in PLOS ONE, October 2012

Altmetric Badge

Mentioned by

twitter: 4 X users
patent: 4 patents

facebook: 1 Facebook page

Citations

dimensions_citation: 35 Dimensions

Readers on

mendeley: 34 Mendeley

Summary X Patents Facebook Dimensions citations

So far, Altmetric has seen 4 patents that reference this research output.

Methods and compositions for treatment of myelodysplastic syndromes and/or acute myeloid…

Grant US-11547696-B2

United States of America

Substituted Imidazo[1,2-a]-pyridines as IRAK 1/4 and FLT3 inhibitors

Grant US-11542261-B2

United States of America

Substituted imidazo[1,2-A]pyridines as IRAK 1/4 and flt3 inhibitors

Grant US-11254667-B2

United States of America

Methods and compositions for the treatment of head and neck cancer

Grant US-10487329-B2

United States of America